Lupus anticoagulants, anticardiolipin antibodies, and fetal loss: A Case–Control Study

New England Journal of Medicine

Volumn 325, Issue 15, 1991, Pages 1063-1066

  Infante Rivard, Claire ^a,b   David, Michèle ^a   Gauthier, Robert ^a   Rivard, Georges Etienne ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FETUS DEATH; FETUS WASTAGE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SPONTANEOUS ABORTION;

EID: 0025997368     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199110103251503     Document Type: Article

References (29)

1. Triplett DA. Antiphospholipid antibodies and recurrent pregnancy loss. Am J Reprod Immunol 1989; 20: 52–67.
2. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990; 74: 1–9.
3. Elias M, Eldor A. Thromboembolism in patients with the “lupus”-type circulating anticoagulant. Arch Intern Med 1984; 144: 510–5.
4. Lockshin MD, Druzin ML, Goei S, et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985; 313: 152–6.
5. Wallenburg HCS. Rotmans N. Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole. Am J Obstet Gynecol 1987; 157: 1230–5.
6. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989; 160: 439–43.
7. Francois A, Freund M, Daffos F, Remy P, Aiach M, Jacquot C. Repeated fetal losses and the lupus anticoagulant. Ann Intern Med 1988; 109: 993–4.
8. Rosove MH, Tabsh K, Wassertrum N, Howard P, Hahn BH, Kalunian KC. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 1990; 75: 630–4.
9. Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood 1986; 68: 869–74.
10. Triplett DA, Brandt JT, Kaczor D, Schaeffer J. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Pathol 1983; 79: 678–82.
11. Lespérance B, David M, Rauch J, Infante-Rivard C, Rivard GE. Relative sensitivity of different tests in the detection of low titer lupus anticoagulants. Thromb Haemost 1988; 60: 217–9.
12. Kline J, Stein Z. Spontaneous abortion (miscarriage). In: Bracken MB, ed. Perinatal epidemiology. New York: Oxford University Press, 1984:23–51.
13. Bakketeig LS, Hoffman HJ, Titmuss Oakley AR. Perinatal mortality. In: Bracken MB, ed. Perinatal epidemiology. New York: Oxford University Press, 1984:99–151.
14. Breslow NE, Day NE. The analysis of case–control studies. Vol. 1 of Statistical methods in cancer research. Lyon, France: International Agency for Research on Cancer, 1980.
15. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989; 79: 340–9.
16. Rodrigues L, Kirkwood BR. Case–control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls. Int J Epidemiol 1990; 19: 205–13.
17. Firkin BG, Booth P. Hendrix L, Howard MA. Demonstration of a platelet bypass mechanism in the clotting system using an acquired anticoagulant. Am J Hematol 1978; 5: 81–92.
18. Brandt JT, Triplett DA. The effect of phospholipid on the detection of lupus anticoagulants by the dilute Russell viper venom time. Arch Pathol Lab Med 1989; 113: 1376–8.
19. Kaczor DA, Bickford NN, Triplett DA. Evaluation of different mixing study reagents and dilution effect in lupus anticoagulant testing. Am J Clin Pathol 1991; 95: 408–11.
20. Harris EN. The Second International Anticardiolipin Standardization Workshop/The Kingston Anti-Phospholipid Antibody study (KAPS) group. Am J Clin Pathol 1990; 94: 476–84.
21. Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161: 369–73.
22. Edelman P, Verdy E, Rouquette AM, et al. Désordres immunologiques de la coagulation dans la maladie abortive. Presse Med 1986; 15: 961–4.
23. Howard MA, Firkin BG, Healy DL, Choong SCC. Lupus anticoagulant in women with spontaneous miscarriage. Am J Hematol 1987; 26: 175–8.
24. Petri M, Golbus M. Anderson R, Whiting-O'Keefe Q, Corash L, Hellman D. Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. Arthritis Rheum 1987; 30: 601–6.
25. Barbui T, Cortelazzo S. Galli M, et al. Antiphospholipid antibodies in early repeated abortions: a case-controlled study. Fertil Steril 1988: 50: 589–92.
26. Maier DB, Parke A. Subclinical autoimmunity in recurrent aborters. Fertil Steril 1989; 51: 280–5.
27. Gladen BC. On the role of ‘habitual aborters’ in the analysis of spontaneous abortion. Stat Med 1986; 5: 557–64.
28. Stirrat GM. Recurrent miscarriage I: definition and epidemiology. Lancet 1990; 336: 673–5.
29. Modvig J, Schmidt L, Damsgaard MT. Measurement of total risk of spontaneous abortion: the virtue of conditional risk estimation. Am J Epidemiol 1990; 132: 1021–38.